RadioTransNet: Preclinical research network coordinated at the SFRO and SFPM.

{"article_title":"RadioTransNet: Preclinical research network coordinated at the SFRO and SFPM.","author":"Maingon P, Marchesi V, Azria D, Balosso J, Deutsch \u00c9, Cohen Jonathan-Moyal \u00c9, Giraud P, Bayart \u00c9","journal_title":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","issn":"1769-6658","isbn":"","publication_date":"2022-02-01","volume":"26","issue":"1-Feb","first_page":"108","page_count":"","accession_number":"34862132","doi":"10.1016\/j.canrad.2021.08.003","publisher":"Elsevier","doctype":"Journal Article","subjects":"France; Biomedical Research organization & administration; Neoplasms radiotherapy; Radiation Oncology; Advisory Committees organization & administration; Combined Modality Therapy methods; Congresses as Topic organization & administration; France; Humans; Neoplasms pathology; Organs at Risk radiation effects; Radiotherapy Dosage; Societies, Medical; Translational Research, Biomedical organization & administration; Tumor Burden","interest_area":["Oncology"," Radiology"],"abstract":"The RadioTransNet programme launched under the auspices of French societies for radiation oncology (SFRO) and medical physics (SFPM) was approved by the French national cancer institute (INCa) in December 2018 and is dedicated to proposing a relevant national and transversal structure for preclinical research including translational research in radiation oncology with well-defined priority areas of research. Its activities, coordinated by a scientific committee that includes radiation oncologists, medical physicists, academic biologists, are structured around several main areas, i.e.: target volume definition, interaction of radiation with normal tissues, combined treatments and modern dose calculation approaches. Four work packages have been created in these areas and are associated with other objectives pertaining to fundamental radiobiology, early implementation of new drugs in a preclinical setting, contribution of imaging in this task, research in medical physics including transversal components such as medical oncology, radiology, nuclear medicine and also cost\/efficiency evaluation. All these tasks will be included in a national network that uses the complementary expertise provided by partners involved in the scheme. Calls for proposals will be selected by the scientific council to be submitted to INCa and the various academic associations to obtain funding for the human and technical resources required to conduct under optimal conditions projects in preclinical and translational research in radiation-oncology. Copyright \u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=34862132","isPdfLink":false,"isSAML":false,"an":"34862132","number_other":"","type_pub":"","issn_electronic":"1769-6658","languages":"English","language":"eng","date_entry":"Date Created: 20211204 Date Completed: 20220217 Latest Revision: 20220217","date_update":"20240105","titleSource":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2022 Feb-Apr; Vol. 26 (1-2), pp. 108-115. Date of Electronic Publication: 2021 Nov 30.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2022-02-01","description":"The RadioTransNet programme launched under the auspices of French societies for radiation oncology (SFRO) and medical physics (SFPM) was approved by the French national cancer institute (INCa) in December 2018 and is dedicated to proposing a relevant national and transversal structure for preclinical research including translational research in radiation oncology with well-defined priority areas of research. Its activities, coordinated by a scientific committee that includes radiation oncologists, medical physicists, academic biologists, are structured around several main areas, i.e.: target volume definition, interaction of radiation with normal tissues, combined treatments and modern dose calculation approaches. Four work packages have been created in these areas and are associated with other objectives pertaining to fundamental radiobiology, early implementation of new drugs in a preclinical setting, contribution of imaging in this task, research in medical physics including transversal components such as medical oncology, radiology, nuclear medicine and also cost\/efficiency evaluation. All these tasks will be included in a national network that uses the complementary expertise provided by partners involved in the scheme. Calls for proposals will be selected by the scientific council to be submitted to INCa and the various academic associations to obtain funding for the human and technical resources required to conduct under optimal conditions projects in preclinical and translational research in radiation-oncology.<br \/> (Copyright © 2021 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.)","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&scope=site&db=mdl&AN=34862132&authtype=shib&custid=ns346513&group=main&profile=eds","no_of_pages":"","authored_by":"Maingon P, Marchesi V, Azria D, Balosso J, Deutsch \u00c9, Cohen Jonathan-Moyal \u00c9, Giraud P, Bayart \u00c9"}